Skip to main content
Log in

Interaction of Topotecan, DNA Topoisomerase I Inhibitor, with Double-Stranded Polydeoxyribonucleotides. 1. Topotecan Dimerization in Solution

  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Behavior of topotecan, DNA topoisomerase I inhibitor, was studied in aqueous solutions by optical methods. Topotecan absorption spectra were recorded in the pH range 0.5–11.5 and its pKa were determined. Quantum chemical calculations were made for all charge states of the topotecan molecule in lactone and carboxylate form. The calculated absorption maxima agree well with the experimental data. Protonation of the topotecan D ring (pKa ≈ 3.6) was revealed. Comparison of experimental and calculated data showed topotecan structure with a proton at the oxygen atom at C16a rather than N4 to be the most preferable. Topotecan molecules were shown to form dimers at concentrations above 10–5M. Topotecan dimerization is accompanied by an increase in the pKa of hydroxy group of the A ring from 6.5 ([TPT] = 10–6M) to 7.1 ([TPT] = 10–4M), which indicates participation of this group in dimer stabilization, perhaps due to intermolecular hydrogen bonding with N1 of the B ring of a neighboring molecule. Probable dimer structures were proposed. The topotecan dimerization constant was determined, K = (4.0 ± 0.7) · 103M–1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gupta, M., Fuijimori, A., and Pommier, Y., Biochim. Biophys. Acta, 1995, vol. 1261, pp. 1–14.

    Google Scholar 

  2. Wang, J.C., Annu. Rev. Biochem., 1996, vol. 65, pp. 635–692.

    Google Scholar 

  3. Kingsbury, W.D., Boehm, J.C., Jakas, D.R., Holden, K.G., Hecht, S.M., Gallagher, G., Caranfa, M.J., McCabe, F.L., Faucett, L.F., Johnson, R.K., and Hertzberg, R.P., J. Med. Chem., 1991, vol. 34, pp. 98–107.

    Google Scholar 

  4. Chen, A.Y. and Liu, L.F., Annu. Rev. Pharmacol. Toxicol., 1994, vol. 94, pp. 194–218.

    Google Scholar 

  5. Hsiang, Y.H., Hertzberg, R., Hecht, S., and Liu, L.F., J. Biol. Chem., 1985, vol. 260, pp. 14873–14878.

    Google Scholar 

  6. Hertzberg, R.P., Busby, R.W., Caranfa, M.J., Holden, K.G., Johnson, R.K., Hecht, S.M., and Kingsbury, W.D., J. Biol. Chem., 1990, vol. 265, pp. 19287–19295.

    Google Scholar 

  7. Rothenberg, M.L., Ann. Oncol., 1997, vol. 8, pp. 837–855.

    Google Scholar 

  8. Li, L.H., Frase, T.J., Olin, E.J., and Bhuyan, B.K., Cancer Res., 1972, vol. 32, pp. 2643–2650.

    Google Scholar 

  9. Kuwahara, J., Suzuki, T., Funakoshi, K., and Sugiura, Y., Biochemistry, 1986, vol. 25, pp. 1216–1221.

    Google Scholar 

  10. Hertzberg, R.P., Caranfa, M.J., and Hecht, S.M., Biochemistry, 1989, vol. 28, pp. 4629–4638.

    Google Scholar 

  11. Yang, A., Strode, J.T., Spielmann, H.P., Wang, A.H.-G., and Burke, T.G., J. Am. Chem. Soc., 1998, vol. 120, pp. 2979–2980.

    Google Scholar 

  12. Yao, S., Murali, D., Seetharamulu, P., Haridas, K., Petluru, P.N.V., Reddy, D.G., and Hausheer, F.H., Cancer Res., 1998, vol. 58, pp. 3782–3786.

    Google Scholar 

  13. Gottlieb, J.A., Guarino, A.M., Call, J.B., Oliverio, V.T., and Bloc, J.B., Cancer. Chemother. Rep., 1970, vol. 54, pp. 461–470.

    Google Scholar 

  14. Nabiev, I., Fleury, F., Kudelina, I., Pommier, Y., Charton, F., Riou, J-F., Alix, A.J.P., and Manfait, M., Biochem. Pharmacol., 1998, vol. 55, pp. 1163–1174.

    Google Scholar 

  15. Dewar, M.J.S., Zoebisch, E.G., Healy, E.F., and Stewart, J.P., J. Am. Chem. Soc., 1985, vol. 107, pp. 3902–3909.

    Google Scholar 

  16. Zerner, M.C., Loew, G.H., Kirchner, R.F., and Mueller-Westerhoff, U.T., J. Am. Chem. Soc., 1980, vol. 102, pp. 589–599.

    Google Scholar 

  17. Lackey, K., Sternbach, D.D., Croom, D.K., Emerson, D.L., Evans, M.G., Leitner, P.L., Luzzio, M.J., McIntyre, G., Vuong, A., Yates, J., and Besterman, J.M., J. Med. Chem., 1996, vol. 39, pp. 713–719.

    Google Scholar 

  18. Fassberg, J. and Stella, V.J.J., Pharm. Sci., 1992, vol. 81, pp. 676–684.

    Google Scholar 

  19. McPhail, A.T. and Sim, G.A., J. Chem. Soc. (B), 1968, pp. 923–928.

  20. Oleinikov, V.A., Mochalov, K.E., Sukhanova, A.V., Ermishev, M.A., Kudelina, I.A., Ustinova, O.A., Streltsov, S.A., Grokhovsky, S.L., Zhuze, A.L., Jardiller, J.-C., and Nabiev, I.R., FEBS Lett. (in press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strel'tsov, S.A., Grokhovskii, S.L., Kudelina, I.A. et al. Interaction of Topotecan, DNA Topoisomerase I Inhibitor, with Double-Stranded Polydeoxyribonucleotides. 1. Topotecan Dimerization in Solution. Molecular Biology 35, 365–373 (2001). https://doi.org/10.1023/A:1010422711817

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010422711817

Navigation